AAAAAA

   
Results: 1-25 | 26-43
Results: 1-25/43
THERAPEUTIC POTENTIAL OF SELECTIVE MODULATORS OF NUCLEAR RECEPTOR ACTION
Authors: RESCHERIGON M GRONEMEYER H
Citation: M. Rescherigon et H. Gronemeyer, THERAPEUTIC POTENTIAL OF SELECTIVE MODULATORS OF NUCLEAR RECEPTOR ACTION, Current opinion in chemical biology, 2(4), 1998, pp. 501-507
SURFACE-ENHANCED RAMAN-SCATTERING AND FLUORESCENCE SPECTROSCOPY REVEAL MOLECULAR-INTERACTIONS OF ALL-TRANS-RETINOIC ACID AND RAR-GAMMA LIGAND-BINDING DOMAIN
Authors: MORJANI H BELJEBBAR A SOCKALINGUM GD MATTIOLI TA BONNIER D GRONEMEYER H MANFAIT M
Citation: H. Morjani et al., SURFACE-ENHANCED RAMAN-SCATTERING AND FLUORESCENCE SPECTROSCOPY REVEAL MOLECULAR-INTERACTIONS OF ALL-TRANS-RETINOIC ACID AND RAR-GAMMA LIGAND-BINDING DOMAIN, Biospectroscopy, 4(5), 1998, pp. 297-302
CONFORMATIONAL ADAPTATION OF AGONISTS TO THE HUMAN NUCLEAR RECEPTOR RAR-GAMMA
Authors: KLAHOLZ BP RENAUD JP MITSCHLER A ZUSI C CHAMBON P GRONEMEYER H MORAS D
Citation: Bp. Klaholz et al., CONFORMATIONAL ADAPTATION OF AGONISTS TO THE HUMAN NUCLEAR RECEPTOR RAR-GAMMA, Nature structural biology, 5(3), 1998, pp. 199-202
THE NUCLEAR RECEPTOR LIGAND-BINDING DOMAIN - STRUCTURE AND FUNCTION
Authors: MORAS D GRONEMEYER H
Citation: D. Moras et H. Gronemeyer, THE NUCLEAR RECEPTOR LIGAND-BINDING DOMAIN - STRUCTURE AND FUNCTION, Current opinion in cell biology, 10(3), 1998, pp. 384-391
THE COACTIVATOR TIF2 CONTAINS 3 NUCLEAR RECEPTOR-BINDING MOTIFS AND MEDIATES TRANSACTIVATION THROUGH CBP BINDING-DEPENDENT AND BINDING-INDEPENDENT PATHWAYS
Authors: VOEGEL JJ HEINE MJS TINI M VIVAT V CHAMBON P GRONEMEYER H
Citation: Jj. Voegel et al., THE COACTIVATOR TIF2 CONTAINS 3 NUCLEAR RECEPTOR-BINDING MOTIFS AND MEDIATES TRANSACTIVATION THROUGH CBP BINDING-DEPENDENT AND BINDING-INDEPENDENT PATHWAYS, EMBO journal, 17(2), 1998, pp. 507-519
LIGAND-INDUCED AND DNA-INDUCED DISSOCIATION OF RXR TETRAMERS
Authors: CHEN ZP IYER J BOURGUET W HELD P MIOSKOWSKI C LEBEAU L NOY N CHAMBON P GRONEMEYER H
Citation: Zp. Chen et al., LIGAND-INDUCED AND DNA-INDUCED DISSOCIATION OF RXR TETRAMERS, Journal of Molecular Biology, 275(1), 1998, pp. 55-65
SEQUENCES IN THE LIGAND-BINDING DOMAINS OF THE HUMAN ANDROGEN AND PROGESTERONE RECEPTORS WHICH DETERMINE THEIR DISTINCT LIGAND IDENTITIES
Authors: VIVAT V GOFFLO D GARCIA T WURTZ JM BOURGUET W PHILIBERT D GRONEMEYER H
Citation: V. Vivat et al., SEQUENCES IN THE LIGAND-BINDING DOMAINS OF THE HUMAN ANDROGEN AND PROGESTERONE RECEPTORS WHICH DETERMINE THEIR DISTINCT LIGAND IDENTITIES, Journal of molecular endocrinology, 18(2), 1997, pp. 147-160
SYNTHETIC GLUCOCORTICOIDS THAT DISSOCIATE TRANSACTIVATION AND AP-1 TRANSREPRESSION EXHIBIT ANTIINFLAMMATORY ACTIVITY IN-VIVO
Authors: VAYSSIERE BM DUPONT S CHOQUART A PETIT F GARCIA T MARCHANDEAU C GRONEMEYER H RESCHERIGON M
Citation: Bm. Vayssiere et al., SYNTHETIC GLUCOCORTICOIDS THAT DISSOCIATE TRANSACTIVATION AND AP-1 TRANSREPRESSION EXHIBIT ANTIINFLAMMATORY ACTIVITY IN-VIVO, Molecular endocrinology, 11(9), 1997, pp. 1245-1255
SYNTHESIS OF A RADIOLABELED RETINOID-X-RECEPTOR (RXR) SPECIFIC LIGAND
Authors: HELD P HECK MP IYER J GRONEMEYER H LEBEAU L MIOSKOWSKI C
Citation: P. Held et al., SYNTHESIS OF A RADIOLABELED RETINOID-X-RECEPTOR (RXR) SPECIFIC LIGAND, Journal of labelled compounds & radiopharmaceuticals, 39(6), 1997, pp. 501-507
A MUTATION MIMICKING LIGAND-INDUCED CONFORMATIONAL CHANGE YIELDS A CONSTITUTIVE RXR THAT SENSES ALLOSTERIC EFFECTS IN HETERODIMERS
Authors: VIVAT V ZECHEL C WURTZ JM BOURGUET W KAGECHIKA H UMEMIYA H SHUDO K MORAS D GRONEMEYER H CHAMBON P
Citation: V. Vivat et al., A MUTATION MIMICKING LIGAND-INDUCED CONFORMATIONAL CHANGE YIELDS A CONSTITUTIVE RXR THAT SENSES ALLOSTERIC EFFECTS IN HETERODIMERS, EMBO journal, 16(18), 1997, pp. 5697-5709
MOLECULAR MECHANISMS OF NUCLEAR RECEPTOR ACTION - A GLUTAMATE CHALLENGE FOR DRUG DESIGN
Authors: GRONEMEYER H
Citation: H. Gronemeyer, MOLECULAR MECHANISMS OF NUCLEAR RECEPTOR ACTION - A GLUTAMATE CHALLENGE FOR DRUG DESIGN, Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 10-10
RETINOBENZOIC ACIDS - VIII - REGULATION OF RETINOIDAL ACTIONS BY DIAZEPINYLBENZOIC ACIDS - RETINOID SYNERGISTS WHICH ACTIVATE THE RXR-RAR HETERODIMERS
Authors: UMEMIYA H FUKASAWA H EBISAWA M EYROLLES L KAWACHI E EISENMANN G GRONEMEYER H HASHIMOTO Y SHUDO K KAGECHIKA H
Citation: H. Umemiya et al., RETINOBENZOIC ACIDS - VIII - REGULATION OF RETINOIDAL ACTIONS BY DIAZEPINYLBENZOIC ACIDS - RETINOID SYNERGISTS WHICH ACTIVATE THE RXR-RAR HETERODIMERS, Journal of medicinal chemistry, 40(26), 1997, pp. 4222-4234
THE DNA-BINDING PATTERN OF THE RETINOID-X-RECEPTOR IS REGULATED BY LIGAND-DEPENDENT MODULATION OF ITS OLIGOMERIC STATE
Authors: KERSTEN S GRONEMEYER H NOY N
Citation: S. Kersten et al., THE DNA-BINDING PATTERN OF THE RETINOID-X-RECEPTOR IS REGULATED BY LIGAND-DEPENDENT MODULATION OF ITS OLIGOMERIC STATE, The Journal of biological chemistry, 272(19), 1997, pp. 12771-12777
ACTION MECHANISM OF RETINOID-SYNERGISTIC DIBENZODIAZEPINES
Authors: UMEMIYA H KAGECHIKA H FUKASAWA H KAWACHI E EBISAWA M HASHIMOTO Y EISENMANN G ERB C PORNON A CHAMBON P GRONEMEYER H SHUDO K
Citation: H. Umemiya et al., ACTION MECHANISM OF RETINOID-SYNERGISTIC DIBENZODIAZEPINES, Biochemical and biophysical research communications, 233(1), 1997, pp. 121-125
PURIFICATION OF THE HUMAN RAR-GAMMA LIGAND-BINDING DOMAIN AND CRYSTALLIZATION OF ITS COMPLEX WITH ALL-TRANS-RETINOIC ACID
Authors: ROCHEL N RENAUD JP RUFF M VIVAT V GRANGER F BONNIER D LEROUGE T CHAMBON P GRONEMEYER H MORAS D
Citation: N. Rochel et al., PURIFICATION OF THE HUMAN RAR-GAMMA LIGAND-BINDING DOMAIN AND CRYSTALLIZATION OF ITS COMPLEX WITH ALL-TRANS-RETINOIC ACID, Biochemical and biophysical research communications, 230(2), 1997, pp. 293-296
A CANONICAL STRUCTURE FOR THE LIGAND-BINDING DOMAIN OF NUCLEAR RECEPTORS (VOL 3, PG 87, 1995)
Authors: WURTZ JM BOURGUET W RENAUD JP VIVAT V CHAMBON P MORAS D GRONEMEYER H
Citation: Jm. Wurtz et al., A CANONICAL STRUCTURE FOR THE LIGAND-BINDING DOMAIN OF NUCLEAR RECEPTORS (VOL 3, PG 87, 1995), Nature structural biology, 3(2), 1996, pp. 206-206
A CANONICAL STRUCTURE FOR THE LIGAND-BINDING DOMAIN OF NUCLEAR RECEPTORS
Authors: WURTZ JM BOURGUET W RENAUD JP VIVAT V CHAMBON P MORAS D GRONEMEYER H
Citation: Jm. Wurtz et al., A CANONICAL STRUCTURE FOR THE LIGAND-BINDING DOMAIN OF NUCLEAR RECEPTORS, Nature structural biology, 3(1), 1996, pp. 87-94
LIGAND-DEPENDENT INTERACTION OF NUCLEAR RECEPTORS WITH POTENTIAL TRANSCRIPTIONAL INTERMEDIARY FACTORS (MEDIATORS)
Authors: LEDOUARIN B BAUR EV ZECHEL C HEERY D HEINE M VIVAT V GRONEMEYER H LOSSON R CHAMBON P
Citation: B. Ledouarin et al., LIGAND-DEPENDENT INTERACTION OF NUCLEAR RECEPTORS WITH POTENTIAL TRANSCRIPTIONAL INTERMEDIARY FACTORS (MEDIATORS), Philosophical transactions-Royal Society of London. Biological sciences, 351(1339), 1996, pp. 569-578
IN-VIVO TARGETED MUTAGENESIS OF A REGULATORY ELEMENT REQUIRED FOR POSITIONING THE HOXD-11 AND HOXD-10 EXPRESSION BOUNDARIES
Authors: GERARD M CHEN JY GRONEMEYER H CHAMBON P DUBOULE D ZAKANY J
Citation: M. Gerard et al., IN-VIVO TARGETED MUTAGENESIS OF A REGULATORY ELEMENT REQUIRED FOR POSITIONING THE HOXD-11 AND HOXD-10 EXPRESSION BOUNDARIES, Genes & development, 10(18), 1996, pp. 2326-2334
MUTATION OF ISOLEUCINE-747 BY A THREONINE ALTERS THE LIGAND RESPONSIVENESS OF THE HUMAN GLUCOCORTICOID RECEPTOR
Authors: ROUX S TEROUANNE B BALAGUER P JAUSONSLOFFREDA N PONS M CHAMBON P GRONEMEYER H NICOLAS JC
Citation: S. Roux et al., MUTATION OF ISOLEUCINE-747 BY A THREONINE ALTERS THE LIGAND RESPONSIVENESS OF THE HUMAN GLUCOCORTICOID RECEPTOR, Molecular endocrinology, 10(10), 1996, pp. 1214-1226
TIF2, A 160 KDA TRANSCRIPTIONAL MEDIATOR FOR THE LIGAND-DEPENDENT ACTIVATION FUNCTION AF-2 OF NUCLEAR RECEPTORS
Authors: VOEGEL JJ HEINE MJS ZECHEL C CHAMBON P GRONEMEYER H
Citation: Jj. Voegel et al., TIF2, A 160 KDA TRANSCRIPTIONAL MEDIATOR FOR THE LIGAND-DEPENDENT ACTIVATION FUNCTION AF-2 OF NUCLEAR RECEPTORS, EMBO journal, 15(14), 1996, pp. 3667-3675
DIFFERENTIAL LIGAND-DEPENDENT INTERACTIONS BETWEEN THE AF-2 ACTIVATING DOMAIN OF NUCLEAR RECEPTORS AND THE PUTATIVE TRANSCRIPTIONAL INTERMEDIARY FACTORS MSUG1 AND TIF1
Authors: BAUR EV ZECHEL C HEERY D HEINE MJS GARNIER JM VIVAT V LEDOUARIN B GRONEMEYER H CHAMBON P LOSSON R
Citation: Ev. Baur et al., DIFFERENTIAL LIGAND-DEPENDENT INTERACTIONS BETWEEN THE AF-2 ACTIVATING DOMAIN OF NUCLEAR RECEPTORS AND THE PUTATIVE TRANSCRIPTIONAL INTERMEDIARY FACTORS MSUG1 AND TIF1, EMBO journal, 15(1), 1996, pp. 110-124
2 DISTINCT ACTIONS OF RETINOID-RECEPTOR LIGANDS
Authors: CHEN JY CLIFFORD J ZUSI C STARRETT J TORTOLANI D OSTROWSKI J RECZEK PR CHAMBON P GRONEMEYER H
Citation: Jy. Chen et al., 2 DISTINCT ACTIONS OF RETINOID-RECEPTOR LIGANDS, Nature, 382(6594), 1996, pp. 819-822
TRANSCRIPTION FACTORS .3. NUCLEAR RECEPTORS
Authors: GRONEMEYER H LAUDET V
Citation: H. Gronemeyer et V. Laudet, TRANSCRIPTION FACTORS .3. NUCLEAR RECEPTORS, Protein profile, 2(11), 1995, pp. 1173-1308
PURIFICATION, FUNCTIONAL-CHARACTERIZATION, AND CRYSTALLIZATION OF THELIGAND-BINDING DOMAIN OF THE RETINOID-X RECEPTOR
Authors: BOURGUET W RUFF M BONNIER D GRANGER F BOEGLIN M CHAMBON P MORAS D GRONEMEYER H
Citation: W. Bourguet et al., PURIFICATION, FUNCTIONAL-CHARACTERIZATION, AND CRYSTALLIZATION OF THELIGAND-BINDING DOMAIN OF THE RETINOID-X RECEPTOR, Protein expression and purification, 6(5), 1995, pp. 604-608
Risultati: 1-25 | 26-43